All In MedTech

FDA Clearance Tracker · P010059-S001

ALCON REFORM CAPSULAR TENSION RING

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 15, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 15, 2004

Approved

Time to decision

55 days

Received Jan 20, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010059-S001
Device name
ALCON REFORM CAPSULAR TENSION RING
Applicant
Morcher GmbH
Applicant location
Stuttgart
Received
Jan 20, 2004
Decided
Mar 15, 2004
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P010059

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MRJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A PRIVATE LABEL DISTRIBUTOR AGREEMENT WITH ALCON LABORATORIES, INC., FORT WORTH, TEXAS. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME ALCON REFORM CAPSULAR TENSION RINGS (MODELS ACTR10, ACTR11, AND ACTR12).

Source documents

Other decisions for Morcher GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.